| Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints D Llobet, J Pallarés, A Yeramian, M Santacana, N Eritja, A Velasco, ... Journal of clinical pathology 62 (9), 777-785, 2009 | 217 | 2009 |
| Autophagy in the physiological endometrium and cancer L Devis-Jauregui, N Eritja, ML Davis, X Matias-Guiu, D Llobet-Navàs Autophagy 17 (5), 1077-1095, 2021 | 132 | 2021 |
| Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma J Pallarés, A Velasco, N Eritja, M Santacana, X Dolcet, M Cuatrecasas, ... Modern Pathology 21 (6), 691-699, 2008 | 97 | 2008 |
| Antioxidants block proteasome inhibitor function in endometrial carcinoma cells D Llobet, N Eritja, M Encinas, A Sorolla, A Yeramian, JA Schoenenberger, ... Anti-cancer drugs 19 (2), 115-124, 2008 | 84 | 2008 |
| Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer N Eritja, BJ Chen, R Rodríguez-Barrueco, M Santacana, S Gatius, A Vidal, ... Autophagy 13 (3), 608-624, 2017 | 82 | 2017 |
| A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis N Eritja, D Llobet, M Domingo, M Santacana, A Yeramian, X Matias-Guiu, ... The American journal of pathology 176 (6), 2722-2731, 2010 | 78 | 2010 |
| CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells D Llobet, N Eritja, M Encinas, N Llecha, A Yeramian, J Pallares, A Sorolla, ... Oncogene 27 (18), 2513-2524, 2008 | 77 | 2008 |
| An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias C Mirantes, N Eritja, MA Dosil, M Santacana, J Pallares, S Gatius, ... Disease models & mechanisms 6 (3), 710-720, 2013 | 66 | 2013 |
| The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms D Llobet, N Eritja, A Yeramian, J Pallares, A Sorolla, M Domingo, ... European Journal of Cancer 46 (4), 836-850, 2010 | 61 | 2010 |
| Endometrial carcinoma: specific targeted pathways N Eritja, A Yeramian, BJ Chen, D Llobet-Navas, E Ortega, E Colas, ... Molecular Genetics of Endometrial Carcinoma, 149-207, 2017 | 60 | 2017 |
| CK2β is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation J Pallares, D Llobet, M Santacana, N Eritja, A Velasco, D Cuevas, ... The American journal of pathology 174 (1), 287-296, 2009 | 59 | 2009 |
| Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture N Chen, N Eritja, R Lock, J Debnath Oncogene 32 (20), 2543-2554, 2013 | 51 | 2013 |
| Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner A Yeramian, M Santacana, A Sorolla, D Llobet, M Encinas, A Velasco, ... Laboratory investigation 91 (6), 859-871, 2011 | 47 | 2011 |
| KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels D Llobet, N Eritja, M Domingo, L Bergada, C Mirantes, M Santacana, ... The American journal of pathology 178 (4), 1529-1543, 2011 | 40 | 2011 |
| Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer I Felip, CP Moiola, C Megino-Luque, C Lopez-Gil, S Cabrera, ... Gynecologic Oncology 153 (2), 425-435, 2019 | 37 | 2019 |
| ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas L Alonso-Alconada, N Eritja, L Muinelo-Romay, J Barbazan, ... Carcinogenesis 35 (12), 2679-2686, 2014 | 36 | 2014 |
| Loss of heterozygosity in endometrial carcinoma A Velasco, J Pallares, M Santacana, A Yeramian, X Dolcet, N Eritja, ... International journal of gynecological pathology 27 (3), 305-317, 2008 | 34 | 2008 |
| Nuclear factor–κB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma P Gallel, J Pallares, X Dolcet, D Llobet, N Eritja, M Santacana, ... Human pathology 39 (7), 994-1001, 2008 | 33 | 2008 |
| Palbociclib has antitumour effects on Pten‐deficient endometrial neoplasias MA Dosil, C Mirantes, N Eritja, I Felip, R Navaridas, S Gatius, ... The Journal of pathology 242 (2), 152-164, 2017 | 32 | 2017 |
| Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometrial cells and drives PTEN loss-induced hyperplasic growth N Eritja, C Mirantes, D Llobet, A Yeramian, L Bergadà, MA Dosil, ... The American Journal of Pathology 183 (1), 277-287, 2013 | 32 | 2013 |
